Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004-2016.
Esben Skov JensenKevin Kris Warnakula OlesenChristine GyldenkernePernille Gro ThraneLisette Okkels JensenBent RaungaardPer Løgstrup PoulsenReimar Wernich ThomsenMichael MængPublished in: BMC cardiovascular disorders (2021)
Between 2004 and 2016, the two-year relative risk of MACE decreased by 30% in patients with diabetes and chronic coronary syndrome, but slightly larger absolute and relative reductions were observed in patients without diabetes.
Keyphrases
- type diabetes
- end stage renal disease
- coronary artery disease
- coronary artery
- cardiovascular disease
- case report
- ejection fraction
- chronic kidney disease
- newly diagnosed
- glycemic control
- aortic stenosis
- prognostic factors
- heart failure
- peritoneal dialysis
- metabolic syndrome
- skeletal muscle
- drug induced
- patient reported